Nucleoside anomeric radicals via 1,5-translocation: Facile access to anomeric spiro nucleosides

Tetrahedron Letters

Volumn 37, Issue 16, 1996, Pages 2801-2804

  Kittaka, Atsushi ^a   Tanaka, Hiromichi ^a   Yamada, Naoki ^a   Miyasaka, Tadashi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

1,5 translocation; 5 endo trig cyclization; anomeric radical; anomeric spiro structure; nucleoside

Indexed keywords

NUCLEOSIDE DERIVATIVE; PURINE DERIVATIVE; SPIRO COMPOUND;

ARTICLE; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0029912414     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(96)00433-9     Document Type: Article

References (21)

1. a) Giese, B.; Dupuis, J. Angew. Chem. Int. Ed. Engl. 1983, 22, 622.
2. b) Giese, B.; Dupuis, J. Tetrahedron Lett. 1984, 25, 1349.
3. c) Adlington, R. M.; Baldwin, J. E.; Basak, A.; Kozyrod, R. P. J. Chem. Soc., Chem. Commun. 1983, 944.
4. a) Kahne, D.; Yang, D.; Lim, J. J.; Miller, R.; Paguaga, E. J. Am. Chem. Soc. 1988, 110, 8716.
5. b) Crich, D.; Hermann, F. Tetrahedron Lett. 1993, 34, 3385.
6. a) Haraguchi, K.; Matsumoto, K.; Itoh, Y.; Tanaka, H.; Miyasaka, T. Nucleic Acids Symposium Series 1994, 31, 29.
7. b) Itoh, Y.; Haraguchi, K.; Tanaka, H.; Matsumoto, K.; Nakamura, K. T.; Miyasaka, T. Tetrahedron Lett. 1995, 36, 3867.
8. c) Gimisis, T.; Ialongo, G.; Zamboni, M.; Chatgilialoglu, C. Tetrahedron Lett. 1995, 36, 6781.
9. For 1,5-translocation of radicals: Curran, D. P.; Shen, W. J. Am. Chem. Soc. 1993, 115, 6051 and references cited therein.
10. Baldwin, J. E.; Cutting, J.; Dupont, W.; Kruse, L.; Silberman, L.; Thomas, R. C. J. Chem. Soc., Chem. Commun. 1976, 736.
11. For a recent example of 5-endo-trig cyclization: Yamamoto, Y.; Ohno, M.; Eguchi, S. J. Am. Chem. Soc. 1995, 117, 9653.
12. Yoshimura, Y.; Otter, B. A.; Ueda, T.; Matsuda, A. Chem. Pharm. Bull. 1992, 40, 1761.
13. a) Tanaka, H.; Hayakawa, H.; Miyasaka, T. Tetrahedron 1982, 38, 2635.
14. b) Tanaka, H.; Uchida, Y.; Shinozaki, M.; Hayakawa, H.; Matsuda, A.; Miyasaka, T. Chem. Pharm. Bull. 1983, 31, 787.
15. c) Shimizu, M.; Tanaka, H.; Hayakawa, H.; Miyasaka, T. Tetrahedron Lett. 1990, 31, 1295.
16. Corey, E. J.; Fuchs, P. L. Tetrahedron Lett. 1972, 3769.
17. The structures of several products (9, 12, 17, 22, 23, 24, 30, and 31) were also confirmed by conversion to reported derivatives: a) Kittaka, A.; Tanaka, H.; Odanaka, Y.; Ohnuki, K.; Yamaguchi, K.; Miyasaka, T. J. Org. Chem. 1994, 59, 3636.
18. b) Kittaka, A.; Tsubaki, Y.; Tanaka, H; Nakamura, K. T.; Miyasaka, T. Nucleosides Nucleotides 1996, 15, in press.
19. 3SnH, ratio of the products (α- and β-anomers) was explained on the basis of both stereoelectronic and steric effects: Baumberger, F.; Vasella, A. Helv. Chim. Acta 1983, 66, 2210.
20. Attempted preparation of 1-(2,3,5-tris-O-TBDMS-β-D-arabinofuranosyl)-6-(2,2-dibromovinyl)uracil failed (TBDMSCl/imidazole/DMF), giving 7 as the sole product.
21. For a recent example of radical 1,6-translocation: Yamazaki, N.; Eichenberger, E.; Curran, D. P. Tetrahedron Lett. 1994, 35, 6623.